From a zero-landfill plant to the historic goal of a zero-landfill National Park system, experience over a decade of our enviromental ingenuity. Explore.
Interestingly, Abou-Elella et al (11) could not confirm that the clinical course of PMLBCL was distinct from diffuse large B-cell lymphoma (DLBCL). Treatment of the lymph node cancer called diffuse large B-cell lymphoma is all-or-nothing. Genes make potential target in lymph cancer. Despite this, indolent disease is typically incurable, with the most aggressive lymphoma subtype - diffuse large B-cell lymphoma having 5-year survival rates of -50%.
A stem cell transplant is the treatment of choice for DLBCL patients. whose cancer has returned or relapsed. High-dose chemotherapy. coupled with a stem cell transplant can be used to treat patients with. DLBCL who have failed initial chemotherapy, but are responsive to a. second chemotherapy regimen.